1. Home
  2. ADTN vs ABCL Comparison

ADTN vs ABCL Comparison

Compare ADTN & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADTRAN Holdings Inc.

ADTN

ADTRAN Holdings Inc.

HOLD

Current Price

$17.03

Market Cap

1.0B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.01

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADTN
ABCL
Founded
1985
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
ADTN
ABCL
Price
$17.03
$4.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$15.50
$8.40
AVG Volume (30 Days)
2.2M
2.5M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
90.83
10.91
EPS
N/A
N/A
Revenue
$1,083,807,000.00
$75,128,000.00
Revenue This Year
$11.18
N/A
Revenue Next Year
$9.38
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
17.46
160.56
52 Week Low
$7.06
$1.94
52 Week High
$16.73
$6.52

Technical Indicators

Market Signals
Indicator
ADTN
ABCL
Relative Strength Index (RSI) 85.43 69.33
Support Level $8.38 $3.91
Resistance Level N/A $4.93
Average True Range (ATR) 0.68 0.16
MACD 0.30 0.06
Stochastic Oscillator 96.16 94.58

Price Performance

Historical Comparison
ADTN
ABCL

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: